<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="cells [99]. Several cyclotides have shown selective cytotoxicity against several" exact="cancer" post="cell lines, including primary cancer cell lines, when compared"/>
 <result pre="shown selective cytotoxicity against several cancer cell lines, including primary" exact="cancer" post="cell lines, when compared to normal cells [100,101,102]. More"/>
 <result pre="and Pombalia calceolaria have shown cytotoxicity against HeLa [103], several" exact="prostate cancer" post="cell lines [104,105], and breast cancer, respectively [106]. Unfortunately,"/>
 <result pre="Pombalia calceolaria have shown cytotoxicity against HeLa [103], several prostate" exact="cancer" post="cell lines [104,105], and breast cancer, respectively [106]. Unfortunately,"/>
 <result pre="against HeLa [103], several prostate cancer cell lines [104,105], and" exact="breast cancer," post="respectively [106]. Unfortunately, the therapeutic index (i.e., the ratio"/>
 <result pre="deficits associated with several psychiatric and neurodegenerative diseases, such as" exact="schizophrenia" post="and Parkinson’s disease. The cyclotide from Viola odorata, Cycloviolacin"/>
 <result pre="to target bradykinin and melanocortin 4 receptors for pain and" exact="obesity" post="management, respectively [30,115]. The kalata B1-based bradykinin antagonist was"/>
 <result pre="cyclotide also showed oral bioavailability in a mouse model of" exact="multiple sclerosis" post="[31]. The treatment with this cyclotide impeded disease progression"/>
 <result pre="of potent antagonists for the cytokine receptor CXCR4 [116]. Many" exact="cancer" post="cells show overexpression of the CXCR4 receptor, which is"/>
 <result pre="novel peptide-based inhibitors of the breakpoint cluster region protein-Abelson murine" exact="leukemia" post="viral oncogene homolog (BCR-ABL) kinase [122]. In this case"/>
 <result pre="did not show significant growth inhibition in an imatinib-sensitive human" exact="chronic myeloid leukemia" post="(CML) cell line. Although this study did not investigate"/>
 <result pre="not show significant growth inhibition in an imatinib-sensitive human chronic" exact="myeloid leukemia" post="(CML) cell line. Although this study did not investigate"/>
 <result pre="show significant growth inhibition in an imatinib-sensitive human chronic myeloid" exact="leukemia" post="(CML) cell line. Although this study did not investigate"/>
 <result pre="in serum. This cyclotide was cytotoxic to several wild-type p53" exact="cancer" post="cell lines by activating the p53 tumor suppressor pathway"/>
 <result pre="reported to have oral activity in a mouse model of" exact="multiple sclerosis" post="[126]. This cyclotide has been recently shown to be"/>
 <result pre="as a target for the development of checkpoint inhibitors for" exact="cancer" post="treatment [131]. A fully folded cyclotide-based genetically-encoded library was"/>
 <result pre="recently used for the production of potent inhibitors of the" exact="anthrax" post="lethal factor protease (Ki ≈ 40 nM) and TNF-α"/>
 <result pre="challenge for the futureFuture Med. Chem.20091659310.4155/fmc.09.1221426071 3.FryD.C.VassilevL.T.Targeting protein-protein interactions for" exact="cancer" post="therapyJ. Mol. Med.20058395596310.1007/s00109-005-0705-x16283145 4.QianZ.DoughertyP.G.PeiD.Targeting intracellular protein-protein interactions with cell-permeable"/>
 <result pre="sequence amino acid scanning of theta-defensin rtd-1 yields a potent" exact="anthrax" post="lethal factor protease inhibitorJ. Med. Chem.2017601916192710.1021/acs.jmedchem.6b0168928151653 67.YangR.WongY.H.NguyenG.K.T.TamJ.P.LescarJ.WuB.Engineering a catalytically"/>
 <result pre="mitochondria-mediated apoptosis via cytochrome c release and caspases activation in" exact="cervical cancer" post="cellsFitoterapia201610916216810.1016/j.fitote.2015.12.02126751970 104.HuE.WangD.ChenJ.TaoX.Novel cyclotides from hedyotis diffusa induce apoptosis and"/>
 <result pre="apoptosis via cytochrome c release and caspases activation in cervical" exact="cancer" post="cellsFitoterapia201610916216810.1016/j.fitote.2015.12.02126751970 104.HuE.WangD.ChenJ.TaoX.Novel cyclotides from hedyotis diffusa induce apoptosis and"/>
 <result pre="hedyotis diffusa induce apoptosis and inhibit proliferation and migration of" exact="prostate cancer" post="cellsInt. J. Clin. Exp. Med.201584059406526064310 105.ZhangH.SongT.YangY.FuC.LiJ.Exploring the interaction mechanism"/>
 <result pre="diffusa induce apoptosis and inhibit proliferation and migration of prostate" exact="cancer" post="cellsInt. J. Clin. Exp. Med.201584059406526064310 105.ZhangH.SongT.YangY.FuC.LiJ.Exploring the interaction mechanism"/>
 <result pre="dynamics simulations and free energy calculationsFront. Chem.2018611910.3389/fchem.2018.0011929755968 106.PintoM.E.NajasJ.Z.MagalhãesL.G.BobeyA.F.MendonçaJ.N.LopesN.P.LemeF.M.TeixeiraS.P.TrovóM.AndricopuloA.D.et al.Inhibition of" exact="breast cancer" post="cell migration by cyclotides isolated from pombalia calceolariaJ. Nat."/>
 <result pre="simulations and free energy calculationsFront. Chem.2018611910.3389/fchem.2018.0011929755968 106.PintoM.E.NajasJ.Z.MagalhãesL.G.BobeyA.F.MendonçaJ.N.LopesN.P.LemeF.M.TeixeiraS.P.TrovóM.AndricopuloA.D.et al.Inhibition of breast" exact="cancer" post="cell migration by cyclotides isolated from pombalia calceolariaJ. Nat."/>
 <result pre="anti-human immunodeficiency virus (hiv)-1 activityJ. Med. Chem.201255107291073410.1021/jm301468k23151033 117.BalkwillF.The significance of" exact="cancer" post="cell expression of the chemokine receptor cxcr4Semin. Cancer Biol.20041417117910.1016/j.semcancer.2003.10.00315246052"/>
 <result pre="untapped antimicrobial drug targetsJ. Antibiot.20177036637710.1038/ja.2016.13827899793 119.GialeliC.TheocharisA.D.KaramanosN.K.Roles of matrix metalloproteinases in" exact="cancer" post="progression and their pharmacological targetingFEBS J.2011278162710.1111/j.1742-4658.2010.07919.x21087457 120.SommerhoffC.P.AvrutinaO.SchmoldtH.U.Gabrijelcic-GeigerD.DiederichsenU.KolmarH.Engineered cystine knot"/>
 <result pre="Rep.201535e0027010.1042/BSR2015021026464514 139.ChanL.Y.CraikD.J.DalyN.L.Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for" exact="cancer" post="therapySci. Rep.201663534710.1038/srep3534727734947 140.SlazakB.KapustaM.MalikS.BohdanowiczJ.KutaE.MalecP.GoranssonU.Immunolocalization of cyclotides in plant cells, tissues"/>
 <result pre="angiogenesis [129] Kalata B1 Immunomodulator 5 and 6 Protecting against" exact="multiple sclerosis" post="[135] Kalata B1 Immunomodulator 4 Protecting against multiple sclerosis"/>
 <result pre="against multiple sclerosis [135] Kalata B1 Immunomodulator 4 Protecting against" exact="multiple sclerosis" post="[31] Trypsin Inhibitor Subfamily MCoTI-I CXCR4 antagonist 6 Anti-metastatic"/>
 <result pre="diseases [114] MCoTI-II CTLA-4 antagonist 1,3, and 6 Immunotherapy for" exact="cancer" post="[130] MCoTI-II Tryptase inhibitor 1 Anti-cancer [43] MCoTI-II VEGF"/>
 <result pre="libraries [74] MCoTI-II BCR-Abl kinase Inhibitor 1 and 6 Chronic" exact="myeloid leukemia" post="Attempt to graft both a cell penetrating peptide and"/>
 <result pre="[74] MCoTI-II BCR-Abl kinase Inhibitor 1 and 6 Chronic myeloid" exact="leukemia" post="Attempt to graft both a cell penetrating peptide and"/>
 <result pre="and kinase inhibitor [122] MCoTI-I MAS1 receptor agonist 6 Lung" exact="cancer" post="and myocardial infarction [64] MCoTI-II SET antagonist 6 Potential"/>
 <result pre="MCoTI-II FXIIa and FXa inhibitors 1 and 6 Antithrombotic and" exact="cardiovascular disease" post="[137] MCoTI-II Thrombospondin-1 (TSP-1) agonist 6 Microvascular endothelial cell"/>
</results>
